Herbal medicine and 'silent witness'.
Article Type: Report
Subject: Medicine, Botanic (Usage)
Medicine, Botanic (Management)
Medicine, Botanic (Practice)
Medicine, Botanic (Complications and side effects)
Medicine, Herbal (Usage)
Medicine, Herbal (Management)
Medicine, Herbal (Practice)
Medicine, Herbal (Complications and side effects)
Author: Thomsen, Michael
Pub Date: 03/22/2010
Publication: Name: Australian Journal of Medical Herbalism Publisher: National Herbalists Association of Australia Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2010 National Herbalists Association of Australia ISSN: 1033-8330
Issue: Date: Spring, 2010 Source Volume: 22 Source Issue: 1
Topic: Event Code: 200 Management dynamics Computer Subject: Company business management
Geographic: Geographic Scope: Australia Geographic Code: 8AUST Australia
Accession Number: 223823987
Full Text: Herbal remedies could be deadly, says forensic pathologist Professor Roger Byard screams the headline in the Adelaide newspaper.

Why does the title of a scholarly article (Byard 2010) change from A Review of the Potential Forensic Significance of Traditional Herbal Medicines to Herbal remedies could be deadly, says forensic pathologist Professor Roger Byard (Saul 2010). Answer: when you want to dumb down medical writing to the masses and sensationalise the issues.

Professor Byard's article basically states that use and abuse of herbal medicines should be considered in forensic pathology. I assume that no one will have any issue with this premise. The article then attempts to examine eight areas: toxic ingredients (mostly heavy metals), substituted ingredients (with the wrong herb), incomplete processing (of aconite for example in TCM), accidental contamination (e.g. pesticides, aflotoxins), adulteration with pharmaceutical drugs, drug interactions, issues with surgery and the problem of identification and detection of organic toxins in the body.

These are all very valid issues for forensic pathology and of course for the practice of herbal medicines. These are serious issues which all needs regulation, policing and education. The problem with Professor Byard's article is that it contains too many inaccurate statements about commonly used herbal medicines. This response is an attempt to correct these inaccuracies.

The publication by Professor Byard is presented as if it were a new study. He has in fact not performed any actual research. His paper is a review of the medical literature. The article is mostly based on other reviews and therefore on second hand references and as result it contains too many erroneous statements.

The concern about heavy metal contamination is not new. In recent times the concern over heavy metal content first surfaced in December 2004 with the publication of an article in the Journal of the American Medical Association which found that 14 Ayurvedic products sold in the Boston area of the United States contained potentially harmful levels of heavy metals.

Although there are published cases of terrible poisoning, especially in India and China but also in Western countries where herbal medicines are either unregulated as food supplements or where the products have been purchased online or in local Asian shops selling unregulated products, we don't actually know how severe the problem is.

Professor Byard himself mentions that only 0.2% of acute medical hospital admissions in Hong Kong were attributed to the use of herbal products in one study. He also quotes Ernst who summarised issues that occur in these cases as 'nonmedically qualified healers, lack of product standards, undeclared ingredients, nondisclosure of usage and long term medication'.

According to the 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS), there was not one death caused by a dietary supplement in 2008 in the US. The new 174 page annual report of the American Association of Poison Control Centers, published in the journal Clinical Toxicology, shows zero deaths from multiple vitamins; zero deaths from any of the B vitamins; zero deaths from vitamins A, C, D or E; and zero deaths from any other vitamin. Additionally there were no deaths whatsoever from any amino acid or herbal product. This means no deaths at all from blue cohosh, echinacea, ginkgo, ginseng, kava, St John's wort, valerian, yohimbe, Asian medicines, Ayurvedic medicines or any other botanical. There were zero deaths from creatine, blue green algae, glucosamine, chondroitin, melatonin or any homeopathic remedy.

Sixty one poison centres provide coast to coast data for the US National Poison Data System, which is then reviewed by 29 medical and clinical toxicologists. NPDS, the authors write, 'is one of the few real time national surveillance systems in existence, providing a model public health surveillance system for all types of exposures, public health event identification, resilience response and situational awareness tracking' (Saul 2010).

Nonetheless the issue of heavy metal contamination is being taken seriously by regulators and associations. In India the Department of AYUSH is working on mandatory testing for heavy metals and in the US the American Herbal Products Association (AHPA) has published a heavy metals white paper it says will assist industry to comply with current Good Manufacturing Practice (cGMP). Heavy metal contamination is a serious problem and it should be addressed by the regulators by imposing mandatory testing for all products, including ingredients (dried herbs and extracts) as well as finished products.

The addition of pharmaceuticals by unscrupulous manufacturers is of course also a serious issue which perhaps needs better policing by the TGA. I must admit I am a bit of a fan of the British pathodrama, Silent Witness, so I read with interest the section on Forensic Implications in Professor Byard's article: 'A range of issues arise with the use of herbal medicines, including problems in determining what might constitute lethal levels of the active ingredients, how a particular herb may have contributed to death, and whether a herb may actually have caused death. The lack of diagnostic pathological findings at autopsy may also create difficulties'.

The references given for this introduction have nothing to do with therapeutic herbal medicine. The first reference refers to a paper by Professor Byard himself (Byard 2002) which describes two cases of poisoning with Datura species, presumably Datura stramonium, also known as thorn apple from the deadly nightshade family. The second reference is about a person who self injected with a toad extract, presumably to get high. The third reference refers to a case of injection of 5-methoxy-N,N-diethyltryptamine from an Auyrvedica formulation. I confess I didn't know this drug so I looked it up: 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a tryptamine derivative and shares many similarities with schedule I tryptamine hallucinogens such as alpha-ethyltryptamine, N,N-dimethyltryptamine, N,N-diethyltryptamine, bufotenine, psilocybin and psilocin. Since 1999 there has been a growing popularity of 5-MeO-DIPT among drug abusers. This substance is abused for its hallucinogenic effects (DrugBank 2010).

Of cause a forensic pathologist needs to know about such poisons, but they are not related to the use of herbal medicine for therapeutic treatments as it is practiced in Australia and other countries.

Prof Byard ends his article by stating: 'The extent of the role of herbal medicines in the types of cases presenting to forensic facilities is yet, however, to be determined'. Exactly, couldn't agree more. Do the research so we can base our actions on facts, not speculation.

Professor Byard also attempts to explain the possible interactions of herbal medicines with pharmaceutical drugs and possible dangers of using herbs during surgery. Unfortunately he just quotes previous reviews instead of drilling down into actual case studies or trials. For the section of surgery he just quotes inaccurate statements about commonly used Western herbs from a review by Dasgupta published in 2006. The over reliance on secondary references is a dangerous practice.

In the following section I have tried to group the statements together and provide a comment.

Statement 1

St John's wort (Hypericum perforatum) induces several cytochrome P450 enzymes and the transporter protein P-glycoprotein and has significant effects on a range of drugs causing reduced anticoagulation by warfarin, decreased action of cyclosporine with acute organ transplant rejections, and intermenstrual bleeding in women taking the oral contraceptive pill.


While it is correct that St John's wort (SJW) should be avoided or used with caution during therapy with warfarin and cyclosporine, the interaction with the oral contraceptive pill is likely to be clinically insignificant.

Three reports suggest a link between SJW and break through bleeding in women taking contraceptives (twice within one week, once within 3 months after start of SJW treatment) (Bon 1999). The case of menstrual break through bleeding three months after having started SJW therapy appears an unusually long delay for an interaction usually apparent after 8-10 days of continuous application and might therefore be unrelated to SJW. In the two women where the bleeding was observed within one week of SJW intake, the reaction fits the general picture observed in clinical trials with preparations rich in hyperforin. It has, in addition, been demonstrated that even if hyperforin enriched St John's wort preparations are responsible for induction of break through bleeding, the anti-ovulatory efficacy of the contraceptive is still not endangered (Hall 2003, Pfrunder 2003).

In any case, St John's wort preparations with normal levels of hyperforin (typically around 1.5-2.0%) have been demonstrated not to cause clinically relevant pharmacokinetic interactions, and thus possess a better safety profile compared with special extracts artificially enriched with hyperforin (Muller 2004, 2006).

Statement 2

St John's wort has significantly reduced the bioavailability of many drugs including serum digoxin, theophylline, amitriptyline, indinavir (an HIV-1 protease inhibitor) and methadone levels, the latter resulting in the re-emergence of withdrawal symptoms.


Only a few of the interactions hitherto detected can be considered clinically relevant. In all of these cases, such as treatment with cyclosporine, indinavir and warfarin, the patients are under a high level of surveillance which should contribute to risk minimisation (Schjulz 2001, 2006, Butterweck 2004) provided that the patients are able to discuss the use of SJW openly with their doctors--which we know is a problem as patients fear that their interests in herbal medicine may be ridiculed, dismissed or ignored by the doctor. It can be quite safely assumed that the risk of clinically relevant interactions is low when preparations containing normal extracts, not enriched in hyperforin, are used. SJW preparations with normal levels of hyperforin (typically around 1.5-2.0%) have been demonstrated not to cause clinically relevant pharmacokinetic interactions and thus possess a better safety profile compared with special extracts enriched with hyperforin (Muller 2004, 2006).

Trials performed with a preparation void of hyperforin failed to show any pharmacokinetic influence in a study on plasma digoxin or contraceptive levels (Brattstrom 2002, Will-Shahab 2008). Another study also failed to demonstrate any interaction between a low hyperforin extract and digoxin in 28 healthy volunteers (verum n=16, placebo n=12) (Arold 2005).

Statement 3

Garlic increased risk of hemorrhage due to inhibition of platelet aggregation and increased fibrinolysis. Ginkgo increased risk of hemorrhage due to inhibition of platelet activating factor. The side effects of both of the above may be worsened if drugs that inhibit platelet aggregation are also being used. Gingko and garlic have increased the risk of bleeding with anticoagulants, while garlic has increased the hepatotoxicity of paracetamol and enhanced the effect of oral hypoglycemic agents. Other preparations may potentiate the action of warfarin thus increasing the risk of hemorrhage; these include dan shen, dong quai, devils claw, ginseng and Siberian ginseng.


It is an often repeated statement that ginkgo (Gingko biloba) and garlic (Allium sativum) may have antiplatelet or anticoagulant effects which could potentially exacerbate the risk of gastrointestinal bleeding from non steroidal anti-inflammatory drugs or corticosteroids, however the reference is of just one case report which discusses a rare and unusual event of excessive garlic ingestion causing a spontaneous spinal epidural hematoma, which would not be considered typical. If Professor Bayard had bothered to look he would have found a study from 2005 concluding: ginkgo and ginger at recommended doses do not significantly affect clotting status, the pharmacokinetics or pharmacodynamics of warfarin in healthy subjects (Jiang 2005).

I have not been able to find any evidence that devil's claw (Harpagophytum procumbens) interacts with warfarin (Medline search).

A study on a product containing Siberian ginseng (Eleutherococcus senticosus) found no significant interaction with warfarin (Hovhannisyan 2006).

Professor Byard quotes the review of Dasgupta (2006) for proof that ginseng interacts with warfarin. However the study referenced in Dasgupta's article is an Australian study from 2004 which concludes: 'coadministration of warfarin with ginseng did not affect the pharmacokinetics or pharmacodynamics of either S-warfarin or R-warfarin

(Jiang 2004).

There has been just one documented case of interaction between dong quai (Angelica sinensis) and warfarin. Dong quai increased the prothrombin time two fold (Page 1999). Dan shen (Salvia miltiorrhiza) may likewise also amplify the anticoagulant effect of warfarin and should be avoided or used with caution (Chan 2001).

Garlic has been shown to increase the toxicity of paracetamol? It is the other way round: garlic may reduce the toxicity of paracetamol.

Acetaminophen, the most commonly sold over the counter antipyretic analgesic, is capable of causing severe and sometimes fatal hepatic damage in humans and experimental animals. The incidence of liver injury due to acetaminophen overdose, either with suicidal intent or by accident, is increasing. Garlic is among those medicinal plants famous for its different health protective effects. In this study the protective effects of garlic extract on acute acetaminophen induced liver injury were investigated using freshly isolated rat hepatocytes. The hepatocytes were isolated from Sprague Dawley male rats by a two step collagenase model. Formation of reactive oxygen species (ROS) and glutathione (GSH) depletion were studied after addition of acetaminophen to cell suspensions. The effects of garlic extract on prevention of ROS formation as well as GSH depletion was investigated and compared with the effects of N-acetyl cysteine (NAC) as the standard treatment. Reactive oxygen species formation was assessed by a spectrofluorometry method and garlic extract was shown to be as effective as NAC in decreasing ROS formation induced by acetaminophen. Glutathione levels of hepatocytes were determined using HPLC. Garlic extract was effective in preventing GSH depletion significantly (p<0.05). It is concluded that garlic extract has an antioxidant effect and can protect hepatocytes from GSH depletion following NAPQI production (Anoush 2009).

Garlic oil has been shown to improve the clearance of the toxic metabolites of the acetaminophen from the liver (Kalantari 2001) and the garlic constituent ajoene has been shown to exhibit a hepatoprotective effect against acetaminophen induced liver injury in mice. A pretreatment with ajoene suppressed the rise in serum glutamic pyruvic transaminase activity and the reduction in the hepatic reduced glutathione level. These effects of ajoene were observed dose dependently (20-100 mg/ kg). The pretreatment by ajoene also suppressed the decrease in hepatic protein thiol content resulting from acetaminophen administration (Hattori 2001).

Garlic has antidiabetic effects, however there are no reports of adverse interactions between oral hypoglycemic agents and garlic. Most likely they can be used together.

Statement 4

Ephedra increased risk of myocardial and cerebral ischemic events; potentially lethal interaction with monoamine oxidase inhibitors; intra operative hemodynamic instability due to reduction of endogenous catecholamines; ventricular arrhythmias with halothane.


These effects are related to ephedrine. The judicious use of the herbal extract of Ephedra sinensis is effective in the treatment of asthma and carries very little risk of such side effects. However as a result of ephedrine misuse the use of Ephedra is banned in many countries including Australia.

Statement 5

Asian ginseng (Panax ginseng) has potentiated the adverse effects of the monoamine oxidase inhibitors, enhanced the effect of oral hypoglycemic agents, decreased the effects of immunosuppressants and had an additive effect with benzodiazepines.

Ginseng: hypoglycemia, reduction of anticoagulation properties of warfarin, increased risk of hemorrhage due to inhibition of platelet aggregation.


Ginseng (Panax ginseng) has antidepressant and anxiolytic activity. The activity may be mediated partly through enhancing the monoamine neurotransmitter concentration and brain derived neurotrophic factor expression in the hippocampus (Dang 2009) but I have not been able to find a report on interaction with MAO inhibitors.

Ginseng may reduce hyperglycaemia in type 2 diabetic patients. Not a bad therapeutic activity, it may reduce the dosage or requirement of oral hypoglycemic medication. There is no evidence it causes hypoglycemia in healthy people. Ginseng has no effect on platelet function in vivo (Beckert 2007) and as mentioned above has no interaction with warfarin.

Statement 6

Certain herbal remedies such as borage oil and evening primrose oil contain gamolenic acid that lowers the seizure threshold in epileptics thus counteracting drugs such as phenobarbitone and phenytoin.


Now where does this crazy statement originate from? It seems to stem from an article by Miller, Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions published in 1998. Miller quotes a book as the reference Herbal Medicines: A Guide for Health Care Professionals published in 1997 (Newall 1997).

I haven't got this book so I can't check the references but in 2007 Puri published a review which related to this particular issue:

'The concern that evening primrose oil might cause epilepsy or seizures, or reduce the threshold for seizures, originated from two papers published in the early 1980s. These original reports are re-examined and the association of evening primrose oil with seizures is shown to be spurious. Not only are linoleic acid and gamma-linolenic acid safe in epilepsy, with prolonged oral administration of linoleic acid and alpha-linolenic acid (in a 4:1 mixture) protecting rats from having seizures in four different epilepsy models, but the evening primrose oil derived omega-6 fatty acid arachidonic acid inhibits sodium ion currents and synaptic transmission, while the evening primrose oil derived eicosanoid prostaglandin E(1) appears to have anticonvulsant activity. In light of these findings it is suggested that formularies should now remove seizures or epilepsy as a side effect of evening primrose oil and should remove a history of seizures or epilepsy as a contraindication to taking evening primrose oil.'

Statement 7

Echinacea: allergic reactions, immunosuppression, reduced efficacy of immunosuppressants.


Allergic reaction to Echinacea spp has been reported but it is extremely rare. Nevertheless allergic reaction may occur (Mullins 2002). There is no clinical evidence that echinacea will reduce the efficacy of immunosuppressants. An in vivo study found no evidence of altered natural killer cell activity, T cell mediated delayed type hypersensitivity, or specific antibody formation in male rats given either a 225 mg/kg or 50 mg/ kg of the commercial echinacea for 6 weeks. Antibody formation was significantly suppressed in female but not male rats given 250 mg/kg for 2 weeks of the commercial echinacea. The local products tested had no effect on antibody formation. We concluded that our study provided no supporting evidence for immunostimulatory activity by the echinacea preparations we examined and in fact may be immunosuppressive under some conditions (South 2001).

Statement 8

Kava and valerian: possible exacerbation of sedative effects of anesthetic agents.


This is poor paraphrasing from the review by Dasgupta (2006) who states that kava (Piper methysticum) should be discontinued at least 24 hours before surgery because kava can increase the sedative effect of anesthetics. Valerian (Valeriana officinalis) is not mentioned in the review by Dasgupta so I assume that Professor Byard has added valerian himself. Both kava and valerian are mild sedatives. I actually doubt it will have much of an impact compared with a pharmaceutical anesthetic, but nevertheless a herbalist would always recommend ceasing all herbal medication 24 hours prior to surgery.

Statement 9

Herbal products may also produce abnormal laboratory results by directly interfering with immunoassays, by increasing or decreasing concentrations of prescribed drugs or by direct hepatotoxicity. The amount of interference due to cross reactivity between herbs and drugs is also dependent on the assay method used for withdrawal symptoms.


Yes they may. Grapefruit is also known to influence drug metabolism. Let us have some more research because there is too much speculation, too much assuming and not enough facts.


Full reference list and download links available from Global Natural Medicine www.globalnaturalmedicine.com.

Michael Thomsen MNHAA

Global Natural Medicine, www.globalnaturalmedicine.com, email michael.thomsen@globalnaturalmedicine.com
Gale Copyright: Copyright 2010 Gale, Cengage Learning. All rights reserved.